Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Brandjes

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
British Journal of Haematology|March 1, 1996
The role of plasma D-dimers concentration in the exclusion of pulmonary embolismE J van Beek, B E Schenk, B C Michel, et al.
American Journal of Hematology|January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot studyJ B Schnog, A P Kater, M R Mac Gillavry, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
British Journal of Haematology|March 1, 1996
The role of plasma D-dimers concentration in the exclusion of pulmonary embolismE J van Beek, B E Schenk, B C Michel, et al.
American Journal of Hematology|January 5, 2002
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot studyJ B Schnog, A P Kater, M R Mac Gillavry, et al.
Pageof 4